Resolve Nanotherapeutics
1 known investors
Resolve Nanotherapeutics develops RNA-based therapies for acute bacterial infections using lipid nanoparticle delivery systems designed to circumvent antibiotic resistance. The company targets serious infections such as pneumonia and peritonitis by combining genetic insights with host-directed therapeutic strategies.
BiotechDeep TechMedical Devices